![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/01/2906418/0/en/Bavarian-Nordic-Converts-Existing-Credit-Facility-into-Sustainability-linked-Loan.html
https://www.globenewswire.com/news-release/2024/06/28/2905952/0/en/Bavarian-Nordic-Joins-Global-Efforts-to-Fight-Mpox-Outbreak-in-Africa.html
https://www.globenewswire.com/news-release/2024/06/26/2904288/0/en/Bavarian-Nordic-Submits-Marketing-Authorization-Application-for-its-Chikungunya-Vaccine-Candidate-to-EMA.html
https://www.globenewswire.com/news-release/2024/06/17/2899781/0/en/Bavarian-Nordic-Completes-BLA-Submission-to-U-S-FDA-for-its-Chikungunya-Vaccine-Candidate.html
https://www.globenewswire.com/news-release/2024/05/31/2891593/0/en/Bavarian-Nordic-Submits-Supplemental-BLA-Seeking-U-S-FDA-Approval-of-Freeze-Dried-Formulation-of-Smallpox-and-Mpox-Vaccine.html
https://www.globenewswire.com/news-release/2024/05/30/2890654/0/en/Bavarian-Nordic-and-CEPI-Partners-to-Advance-Mpox-Vaccination-in-Africa.html
https://www.globenewswire.com/news-release/2024/05/22/2886241/0/en/Capital-Increase-in-Bavarian-Nordic-A-S-as-a-Result-of-Employee-Warrant-Exercise.html
https://www.globenewswire.com/news-release/2024/05/21/2886084/0/en/Bavarian-Nordic-Transactions-in-Connection-with-Share-Buy-Back-Program-and-Termination-of-Share-Buy-Back-Program.html
https://www.globenewswire.com/news-release/2024/05/21/2885494/0/en/EVP-and-Chief-Medical-Officer-Laurence-de-Moerlooze-Will-Be-Leaving-Bavarian-Nordic.html
https://www.globenewswire.com/news-release/2024/05/08/2877433/0/en/Bavarian-Nordic-Launches-Share-Buy-Back-Program-to-Hedge-Incentive-Scheme-Obligations.html